| Name | Title | Contact Details |
|---|
Oden Machinery, Inc. provides customers worldwide with liquid filling and processing machinery backed by over three decades of industry-leading innovation in design and engineering solutions. Oden is a leading U.S. manufacturer of filling and processing machinery for the liquid products markets and provides complete turnkey liquid packaging lines. Custom designed systems for form/fill/seal, bag-in-box, retort, explosion proof, and other specialized liquid packaging applications are also available. In August 2010, Oden partnered with Green Frontier LLC to help companies optimize their liquid processing operations and reduce their impact on the environment. The Oden Process Equipment Group offers continuous stream digital blending systems, automated batch addition systems, and liquid product transfer systems, all designed to reduce labor costs, enhance product quality, increase production capacity, and decrease generation of waste and scrap. Our customers businesses span a broad range of industries, including pharmaceutical, personal care products, food processing, household products, general industrial, automotive products, petroleum products, and the chemical processing industries. If your packaging/processing operations include filling or processing liquid products, we encourage you to visit www.odencorp.com. If you need an off the shelf" machine or require highly specialized machinery give us a call, 800-658-3622.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
capSpire propels energy and commodity businesses forward by blending human ingenuity with deep market expertise to solve complex challenges. Our mission is to deliver transformative solutions that empower businesses to grow, scale, and succeed. With three integrated services—Advisory, Delivery, and Operations and Support—capSpire offers holistic solutions that start with strategy and carry clients seamlessly through to scale. What sets capSpire apart is our ability to connect every stage of the value chain, delivering tailored solutions that integrate technology, processes, and industry insight. From strategy consulting and technology implementation to operational excellence, we strive to ensure that every solution drives measurable impact and uncovers new growth opportunities. At capSpire, we dont just implement solutions; we become an extension of your team. We empower businesses to maximize their investments and push forward—confidently and strategically—into the future. Together, well power forward.
Bigelow is the M + A Advisor exclusively for owners of high-performing private companies — Entrepreneur Owner-Managers with their skin in the game. Our scrappy boutique firm behaves as one collaborative team. Leveraging our independence and exclusive EOM focus, we have helped hundreds of clients build and capture Enterprise Value while respecting their values, their legacy and the intersection of their professional and personal goals. Frequently our work with clients goes on for years in advance of a wealth-building transaction. Unlike virtually all of the firms with which we compete, we are independently owned. We have only one source of revenue — our Entrepreneur Owner-Manager clients. No referral fees. No investing, trading, lending, or underwriting. No buy-side advisory. No products to sell. No conflicts. We aspire to be completely aligned with achieving our clients potential, striving endlessly to be masters of our craft.